In lung cancer, Nrp2 expression is correlated with advanced disease stage at diagnosis, epithelial-to-mesenchymal transition (EMT), metastasis, decreased survival, and drug resistance [88,89,90,91,92]. This evidence concerns the gene NRP2 and lung cancer.